Cartesian Therapeutics Statistics

Total Valuation

RNAC has a market cap or net worth of $470.35 million. The enterprise value is $377.39 million.

Market Cap	470.35M
Enterprise Value	377.39M

Important Dates

The last earnings date was Wednesday, May 8, 2024, before market open.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

RNAC has 17.80 million shares outstanding. The number of shares has increased by 5.92% in one year.

Shares Outstanding	17.80M
Shares Change (YoY)	+5.92%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	60.73%
Owned by Institutions (%)	11.83%
Float	3.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	25.45
PS Ratio	18.16
Forward PS	92.23
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.03

Current Ratio	3.03
Quick Ratio	2.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-134.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-116.40%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$700,162
Profits Per Employee	-$6.89M
Employee Count	37
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	-19.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.63% in the last 52 weeks. The beta is 0.83, so RNAC's price volatility has been lower than the market average.

Beta (1Y)	0.83
52-Week Price Change	-20.63%
50-Day Moving Average	19.96
200-Day Moving Average	26.30
Relative Strength Index (RSI)	65.96
Average Volume (30 Days)	69,622

Short Selling Information

The latest short interest is 784,229, so 4.41% of the outstanding shares have been sold short.

Short Interest	784,229
Short Previous Month	638,538
Short % of Shares Out	4.41%
Short % of Float	21.87%
Short Ratio (days to cover)	6.59

Income Statement

In the last 12 months, RNAC had revenue of $25.91 million and -$254.87 million in losses. Loss per share was -$56.10.

Revenue	25.91M
Gross Profit	25.91M
Operating Income	-81.38M
Pretax Income	-273.87M
Net Income	-254.87M
EBITDA	-269.18M
EBIT	-271.85M
Loss Per Share	-$56.10

Full Income Statement

Balance Sheet

The company has $103.42 million in cash and $10.46 million in debt, giving a net cash position of $92.96 million or $5.22 per share.

Cash & Cash Equivalents	103.42M
Total Debt	10.46M
Net Cash	92.96M
Net Cash Per Share	$5.22
Equity / Book Value	-116.80M
Book Value Per Share	-6.56
Working Capital	74.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$58.31 million and capital expenditures -$678,000, giving a free cash flow of -$58.99 million.

Operating Cash Flow	-58.31M
Capital Expenditures	-678,000
Free Cash Flow	-58.99M
FCF Per Share	-$10.90

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -314.15% and -983.83%.

Gross Margin	100.00%
Operating Margin	-314.15%
Pretax Margin	-1,057.17%
Profit Margin	-983.83%
EBITDA Margin	-1,039.05%
EBIT Margin	-1,049.36%
FCF Margin	-227.71%

Dividends & Yields

RNAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.92%
Shareholder Yield	-5.92%
Earnings Yield	-54.19%
FCF Yield	-12.54%

Analyst Forecast

The average price target for RNAC is $45.00, which is 65.14% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$45.00
Price Target Difference	65.14%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	17.53%
EPS Growth Forecast (5Y)	-37.86%

Stock Forecasts

Stock Splits

The last stock split was on April 5, 2024. It was a reverse split with a ratio of 1:30.

Last Split Date	Apr 5, 2024
Split Type	Reverse
Split Ratio	1:30

Scores

RNAC has an Altman Z-Score of -4.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.66
Piotroski F-Score	2